Advanced Search
Displaying assets from 1 to 30 out of 3
-
Description Mean (±SD) sirukumab serum concentration–time profiles following a single intravenous infusion of sirukumab in healthy subjects.
Article Title: Pharmacokinetics, pharmacodynamics and safety of a human anti‐IL‐6 monoclonal antibody (sirukumab) in healthy subjects in a first‐in‐human study
Publication Title: British Journal of Clinical Pharmacology -
Description Percent change from baseline in C‐reactive protein (CRP) serum concentration following a single intravenous administration of sirukumab in healthy subjects.
Article Title: Pharmacokinetics, pharmacodynamics and safety of a human anti‐IL‐6 monoclonal antibody (sirukumab) in healthy subjects in a first‐in‐human study
Publication Title: British Journal of Clinical Pharmacology -
Description Dose‐proportionality assessment of sirukumab pharmacokinetics in healthy subjects. Left panel: Mean ± SD values for Cmaxvs. dose for subjects in each cohort with the linear regression line defined...
Article Title: Pharmacokinetics, pharmacodynamics and safety of a human anti‐IL‐6 monoclonal antibody (sirukumab) in healthy subjects in a first‐in‐human study
Publication Title: British Journal of Clinical Pharmacology